Wolfgang Dummer - 02 Oct 2023 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Role
Chief Medical Officer
Signature
/s/ James Paul Rickey
Issuer symbol
N/A
Transactions as of
02 Oct 2023
Net transactions value
$0
Form type
4
Filing time
04 Oct 2023, 17:14:13 UTC
Previous filing
06 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALPN Stock Option (Right to buy) Award $0 +200,000 $0.000000 200,000 02 Oct 2023 Common Stock 200,000 $11.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4) of the shares subject to the option will vest on October 2, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to be a service provider through each such date.